-
公开(公告)号:US20230330258A1
公开(公告)日:2023-10-19
申请号:US18054018
申请日:2022-11-09
发明人: Christian HACKENBERGER , Marc-André KASPER , Philipp OCHTROP , Jahaziel JAHZERAH , Paul MACHUI , Dominik SCHUMACHER , Jonas HELMA-SMETS , Isabelle MAI
CPC分类号: A61K47/6889 , C07F9/30
摘要: The present invention relates to a conjugate having the formula (I):
wherein a receptor binding molecule (RBM) is connected with a drug moiety (D). The present invention also relates to intermediates for producing the same, methods of preparing the same, pharmaceutical compositions comprising the same, as well as uses thereof.-
公开(公告)号:US20220193251A1
公开(公告)日:2022-06-23
申请号:US17559664
申请日:2021-12-22
发明人: Heinrich LEONHARDT , Jonas HELMA-SMETS , Dominik SCHUMACHER , Marcus GERLACH , Christian PR HACKENBERGER , Marc-André KASPER
IPC分类号: A61K47/68
摘要: The present invention relates to an antibody-drug conjugate (ADC) comprising: (a) Brentuximab, wherein Brentuximab comprises at the C-terminus of the light chains, the heavy chains or all of the heavy and light chains of the Brentuximab a recognition sequence for tubulin tyrosine ligase and a non-natural amino acid; and (b) at least one drug moiety; wherein a drug moiety is coupled to each of the non-natural amino acids via a linker. The present invention further relates to methods of producing same, pharmaceutical compositions comprising same as well as uses thereof.
-
公开(公告)号:US20240350655A1
公开(公告)日:2024-10-24
申请号:US18556602
申请日:2022-04-22
发明人: Christian Ewald STIEGER , Christian Peter Richard HACKENBERGER , Marc-André KASPER , Philipp OCHTROP
IPC分类号: A61K47/68 , A61K47/54 , C07F9/32 , C07F9/6518 , C07F9/6524 , C07F9/653 , C07F9/6558 , C07F9/6561
CPC分类号: A61K47/6851 , A61K47/548 , A61K47/68031 , C07F9/3217 , C07F9/6518 , C07F9/6524 , C07F9/65324 , C07F9/65583 , C07F9/65586 , C07F9/6561
摘要: Disclosed are novel conjugates and methods for the preparation thereof. One of the methods for the preparation of a conjugate comprises a step of: acting a compound of formula (I), with a thiol-containing molecule of formula (II), wherein represents an amino acid, a peptide, a protein, an antibody, a nucleotide, an oligonucleotide, a saccharide, a polysaccharide, a polymer, a small molecule, an optionally substituted C1-C8-alkyl, an optionally substituted phenyl, or an optionally substituted aromatic 5- or 6-membered heterocyclic system; resulting in a compound of formula (III).
-
-